FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today reported financial results for the fourth quarter and fiscal year ended June 30, 2007. Highlights of fiscal 2007 and other Company initiatives to date include:
